Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome
Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome have?
Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome has 108 citations in the OpenAlex counts ScholarIQ stores.
When was Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome published?
Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome has 2023 year in the ScholarIQ index.
What is the open-access status of Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome?
Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome has gold oa status in the ScholarIQ index.
What is the DOI of Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome?
The DOI for Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome is on the source record.
What is the PMID of Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome?
The PMID for Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome is on the source record.
What is the OpenAlex record for Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome?
The OpenAlex for Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome is on the source record.